Exicure Inc
XCUR3.840USD
-0.040-1.03%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
24.26MMarket Cap
LossP/E TTM
More Details of Exicure Inc Company
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Company Info
Ticker SymbolXCUR
Company nameExicure Inc
IPO dateMay 09, 2018
CEOMr. Paul Kang
Number of employees7
Security typeOrdinary Share
Fiscal year-endMay 09
Address2430 N. Halsted St.
CityCHICAGO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code60614
Phone18476731707
Websitehttps://www.exicuretx.com/
Ticker SymbolXCUR
IPO dateMay 09, 2018
CEOMr. Paul Kang
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Director
Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Director
Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Joshua (Josh) Miller
Mr. Joshua (Josh) Miller
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Paul Kang
Mr. Paul Kang
Director
Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Paul Kang
Mr. Paul Kang
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Director
Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Director
Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Joshua (Josh) Miller
Mr. Joshua (Josh) Miller
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Aug 29
Updated: Fri, Aug 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hitron Systems Inc Employees
52.76%
DGP Co., Ltd.
7.80%
Sangsangin Investment & Securities Co. Ltd.
6.86%
Abingworth Management Limited
4.46%
CBI USA, Inc.
2.59%
Other
25.53%
Shareholders
Shareholders
Proportion
Hitron Systems Inc Employees
52.76%
DGP Co., Ltd.
7.80%
Sangsangin Investment & Securities Co. Ltd.
6.86%
Abingworth Management Limited
4.46%
CBI USA, Inc.
2.59%
Other
25.53%
Shareholder Types
Shareholders
Proportion
Corporation
63.15%
Research Firm
6.87%
Venture Capital
4.46%
Investment Advisor
0.90%
Investment Advisor/Hedge Fund
0.31%
Hedge Fund
0.18%
Endowment Fund
0.17%
Other
23.97%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
39
5.19M
82.14%
+459.49K
2025Q1
39
5.11M
80.94%
+626.75K
2024Q4
39
2.19M
79.53%
+1.26M
2024Q3
38
1.16M
47.48%
+231.16K
2024Q2
41
935.92K
56.32%
-7.21K
2024Q1
63
954.65K
57.41%
-102.69K
2023Q4
69
1.01M
60.85%
-61.54K
2023Q3
83
1.06M
66.48%
-70.11K
2023Q2
96
1.06M
66.44%
-83.25K
2023Q1
130
1.14M
110.73%
-98.99K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hitron Systems Inc Employees
3.33M
52.76%
--
--
Mar 12, 2025
DGP Co., Ltd.
849.22K
13.44%
+237.22K
+38.76%
Sep 12, 2024
Abingworth Management Limited
281.64K
4.46%
--
--
Mar 31, 2025
CBI USA, Inc.
163.66K
2.59%
--
--
Sep 12, 2024
The Vanguard Group, Inc.
19.03K
0.3%
+19.03K
--
Mar 31, 2025
UBS Financial Services, Inc.
566.00
0.01%
-1.07K
-65.49%
Mar 31, 2025
Geode Capital Management, L.L.C.
19.10K
0.3%
+6.45K
+51.03%
Mar 31, 2025
Northwestern University
10.43K
0.17%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Date
Type
Ratio
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
